Search Results - "Bommareddy, Praveen K."
-
1
Integrating oncolytic viruses in combination cancer immunotherapy
Published in Nature reviews. Immunology (01-08-2018)“…Oncolytic viruses can be usefully integrated into tumour immunotherapies, as they target multiple steps within the cancer–immunity cycle. Oncolytic viruses…”
Get full text
Journal Article -
2
Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
Published in Oncoimmunology (03-07-2019)“…Successful immunotherapy for melanoma depends on the recruitment of effector CD8 + T cells to the tumor microenvironment. Factors contributing to T cell…”
Get full text
Journal Article -
3
Oncolytic Herpes Simplex Virus Encoding IL12 Controls Triple-Negative Breast Cancer Growth and Metastasis
Published in Frontiers in oncology (24-03-2020)“…Triple-negative breast cancer (TNBC) is a difficult-to-treat disease with high rates of local recurrence, distant metastasis, and poor overall survival with…”
Get full text
Journal Article -
4
Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies
Published in Frontiers in oncology (11-09-2017)“…There has long been interest in innovating an approach by which tumor cells can be selectively and specifically targeted and destroyed. The discovery of…”
Get full text
Journal Article -
5
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1
Published in Journal for immunotherapy of cancer (10-08-2019)“…Oncolytic viruses preferentially replicate in tumors as compared to normal tissue and promote immunogenic cell death and induction of host systemic anti-tumor…”
Get full text
Journal Article -
6
Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
Published in American journal of clinical dermatology (01-02-2017)Get full text
Journal Article -
7
Two roads for oncolytic immunotherapy development
Published in Journal for immunotherapy of cancer (01-02-2019)“…Oncolytic viruses are an emerging class of immunotherapy agents for cancer treatment. In this issue of JITC, Machiels et al. reports early phase data from an…”
Get full text
Journal Article -
8
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival
Published in Journal for immunotherapy of cancer (09-04-2024)“…BackgroundGlioblastoma (GBM), a highly immunosuppressive and often fatal primary brain tumor, lacks effective treatment options. GBMs contain a subpopulation…”
Get full text
Journal Article -
9
Sensory-Derived Glutamate Regulates Presynaptic Inhibitory Terminals in Mouse Spinal Cord
Published in Neuron (Cambridge, Mass.) (15-06-2016)“…Circuit function in the CNS relies on the balanced interplay of excitatory and inhibitory synaptic signaling. How neuronal activity influences synaptic…”
Get full text
Journal Article -
10
A Water-Soluble Antibiotic in Rhubarb Stalk Shows an Unusual Pattern of Multiple Zones of Inhibition and Preferentially Kills Slow-Growing Bacteria
Published in Antibiotics (Basel) (06-08-2021)“…Organic extract of Rhubarb (Rheum officinale) roots is known to have several medicinal uses. However, not much research has been done with the rhubarb stalk…”
Get full text
Journal Article -
11
Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer
Published in Oncogene (01-07-2018)“…BMP receptor inhibitors induce death of cancer cells through the downregulation of antiapoptotic proteins XIAP, pTAK1, and Id1-Id3. However, the current most…”
Get full text
Journal Article -
12
Oncolytic Herpes Simplex Viruses as a Paradigm for the Treatment of Cancer
Published in Annual review of cancer biology (04-03-2018)“…Oncolytic viruses are native or modified viruses that directly kill tumor cells but spare normal tissue and promote host antitumor immunity. Recently, an…”
Get full text
Journal Article -
13
Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade
Published in Oncoimmunology (03-04-2019)“…In a recent edition of Science Translational Medicine, we identified an enhanced therapeutic activity when talimogene laherparepvec (T-VEC) was combined with…”
Get full text
Journal Article -
14
A Role for Dystonia-Associated Genes in Spinal GABAergic Interneuron Circuitry
Published in Cell reports (Cambridge) (17-10-2017)“…Spinal interneurons are critical modulators of motor circuit function. In the dorsal spinal cord, a set of interneurons called GABApre presynaptically…”
Get full text
Journal Article -
15
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer
Published in Journal for immunotherapy of cancer (01-07-2023)“…BackgroundImmunotherapies are becoming front-line treatments for many advanced cancers, and combinations of two or more therapies are beginning to be…”
Get full text
Journal Article -
16
Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
Published in American journal of clinical dermatology (01-02-2017)“…Many mammalian viruses have properties that can be commandeered for the treatment of cancer. These characteristics include preferential infection and…”
Get full text
Journal Article -
17
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma
Published in Frontiers in oncology (10-01-2020)“…High-dose ipilimumab (IPI) and high-dose interleukin-2 (IL-2) are approved agents for metastatic melanoma, but the efficacy and safety of the combination are…”
Get full text
Journal Article -
18
MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation
Published in Science translational medicine (12-12-2018)“…Melanoma is an aggressive cutaneous malignancy, but advances over the past decade have resulted in multiple new therapeutic options, including molecularly…”
Get more information
Journal Article -
19
Optimal timing of PD-1 blockade in combination with oncolytic virus therapy
Published in Seminars in cancer biology (01-11-2022)“…Anti-PD-1 and oncolytic viruses (OVs) have non-overlapping anti-tumor mechanisms, since each agent works at different steps of the cancer-immunity cycle…”
Get full text
Journal Article -
20
Multi-parametric flow cytometry staining procedure for analyzing tumor-infiltrating immune cells following oncolytic herpes simplex virus immunotherapy in intracranial glioblastoma
Published in Journal of biological methods (04-04-2019)“…Multi-color flow cytometry is a standard laboratory protocol, which is regularly used to analyze tumor-infiltrating immune cell subsets. Oncolytic herpes…”
Get full text
Journal Article